Pro Health Tips
Thursday, 25 November 2021
Study Reports Effectiveness of BBV152 Against COVID-19
The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19.
from Medindia Health News https://ift.tt/3HVqnkL
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19.
No comments:
Post a Comment